Nordea Investment Management’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.24M Sell
29,288
-2,369
-7% -$309K ﹤0.01% 640
2026
Q1
$3.97M Sell
31,657
-1,101
-3% -$158K ﹤0.01% 633
2025
Q4
$4.71M Sell
32,758
-4,380
-12% -$587K ﹤0.01% 601
2025
Q3
$4.32M Buy
37,138
+1,400
+4% +$177K ﹤0.01% 622
2025
Q2
$4.69M Buy
35,738
+4
+0% +$542 ﹤0.01% 572
2025
Q1
$4.88M Buy
+35,734
New +$5.55M 0.01% 537

Other funds holding ICUI

Nordea Investment Management's ICUI Position: Q2 2026 in Review

Nordea Investment Management reduced its ICU Medical (ICUI) stake by 7.5% in Q2 2026, selling an estimated $309K and leaving 29,288 shares worth $4.24M. The position accounts for ﹤0.01% of the portfolio, ranked #640.

Nordea Investment Management first reported a position in ICUI in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.88M in Q1 2025. 288 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

  • Nordea Investment Management held 29,288 shares of ICU Medical worth $4.24M as of Q2 2026.
  • Nordea Investment Management sold 2,369 ICU Medical shares in Q2 2026, an estimated $309K.
  • ICU Medical made up ﹤0.01% of Nordea Investment Management's portfolio in Q2 2026, its #640 holding.
  • Nordea Investment Management first reported a position in ICU Medical in Q1 2025 and has held it in 6 quarters since.
  • Nordea Investment Management's ICU Medical position peaked at $4.88M in Q1 2025.
  • 288 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.